Main menu

Responsibility

Why We Disclose Payments to Health Care Professionals

Why and How We Disclose Payments to Health Care Professionals

We want people to know, and understand, what we do: We want to be clear about our payments to health care providers and clinical investigators. Sharing this information in a simple and uniform manner helps patients and other interested parties to accurately understand these valuable relationships.

We have a record of being clear about what we do: This is a natural extension of our commitment to providing greater transparency into our business operations:

  • 2007: Pfizer led the industry by reporting its post-marketing commitments on Pfizer.com.
  • 2008: Pfizer began reporting its non-clinical grants and charitable contributions to patient, medical and scientific organizations.
  • 2009: Pfizer began collecting physician payment data for public reporting.

We report payments for a range of activities with physicians: We want patients to understand the way we work with health care professionals:

  • We include payments to practicing physicians and other health care providers, as well as to principal investigators and institutions for Phase I-IV clinical trials sponsored by Pfizer, begun after July 1, 2009.
  • We also report payments to major institutions for clinical trials ongoing as of July 1, 2009, and to principal investigators and all other entities for investigator-initiated research.
  • We subsequently included these disclosures, as a requirement, in Pfizer's August 2009 Corporate Integrity Agreement with the Office of the Inspector General of the Department of Health and Human Services.

View the Payments Report

Have a Question?

Have a Question?

We want to hear from you.